Antineoplastics: Myelodysplastic syndrome and chronic myelomonocytic leukaemia: case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1211, 2008-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antineoplastics: Chronic myelomonocytic leukaemia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1394, 2012-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Antineoplastics: Chronic myelomonocytic leukaemia treated with imatinib: case report

By  

Reactions Weekly, Vol. 1, Iss. 1324, 2010-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Cyclophosphamide: Myelodysplastic syndrome and acute myelomonocytic leukaemia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1234, 2009-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Antineoplastics: Acute myeloid leukaemia and myelodysplastic syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1029, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Antineoplastics/idarubicin: Secondary chronic myelomonocytic leukaemia (first report for idarubicin, mercaptopurine, mitoxantrone and tretinoin): case report

By  

Reactions Weekly, Vol. 1, Iss. 1208, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite